Eloxx receives Nasdaq extension to Oct 9, 2023 to meet $35M market value rule

Eloxx Pharmaceuticals, Inc.

Nasdaq Hearings Panel extended compliance deadline for Listing Rule 5550(b)(2) from July 30 to October 9, 2023.
Company must maintain at least $35 million market value of listed securities to avoid delisting.
Extension follows a May 18, 2023 hearing and a July 27, 2023 request by Eloxx.
Failure to regain compliance by October 9 could result in delisting from Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.